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Introduction
An unresolved feature of the Golgi complex is the role of mem-
brane tubules in trafficking and maintenance of Golgi architec-
ture (Bard and Malhotra, 2006; Pfeffer, 2007; De Matteis and 
Luini, 2008). Within the Golgi, membrane tubules are implicated 
in cis to trans cargo transport (Marsh et al., 2004; Trucco et al., 
2004), retrograde trafficking to the ER (Lippincott-Schwartz et al., 
1989; Saraste and Svensson, 1991), transport from the TGN to 
the cell surface and endosomes (Puertollano et al., 2001; Waguri 
et al., 2003; Bard and Malhotra, 2006; De Matteis and Luini, 
2008), and in the assembly and maintenance of intact Golgi 
ribbons (de Figueiredo et al., 1998, 1999).
Pharmacological studies have shown cytoplasmic phos-
pholipase A2 (PLA2) enzymes regulate the formation of Golgi 
membrane tubules that contribute to retrograde trafficking, and 
the assembly and maintenance of an intact Golgi ribbon in 
mammalian cells (de Figueiredo et al., 1998, 1999, 2000; 
Drecktrah and Brown, 1999; Polizotto et al., 1999; Brown et al., 
2003). Here we identify platelet-activating factor acetylhydro-
lase (PAFAH) Ib as a cytoplasmic PLA2 complex that regulates 
membrane tubule formation and organization and function of 
the Golgi complex. PAFAH Ib was originally purified based on 
its ability to hydrolyze the sn-2 position acetyl group of the 
signal-transducing, phosphatidylcholine derivative, platelet- 
activating factor (PAF; Hattori et al., 1993, 1994a,b). PAFAH Ib 
consists of homo- or hetero-dimers of two closely related cata-
lytic subunits, 1 (Pafah1b3) and 2 (Pafah1b2), and a non-
catalytic dimer of  subunits (Pafah1b1; Ho et al., 1997; Arai 
et al., 2002; Tarricone et al., 2004). The  subunit is better known 
as LIS1, the causative agent of the fatal brain disorder Miller-
Dieker lissencephaly (Kato and Dobyns, 2003). LIS1 is a highly 
conserved protein involved in dynein-mediated processes 
including nuclear and neuronal migration, centrosomal func-
tion, and mitotic spindle orientation (Kerjan and Gleeson, 2007; 
Vallee and Tsai, 2006). Although PAFAH Ib has been impli-
cated in a variety of processes, including the regulation of PAF 
and LIS1 functions, its exact biological function is unclear, as 
1//2/ double-knockout mice, although exhibiting defects 
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(Fig. 1 B). Other proteins identified in the GF fraction were 
Hsc70, PLA2-activating protein (PLAA), and fructose bis-
phosphate aldolase. A variety of experiments showed that aldol-
ase is a contaminant; the role of Hsc70 and PLAA in tubule 
formation, if any, remains to be determined.
To determine if PAFAH Ib is directly involved in mem-
brane tubule formation, purified 1 or 2 was added to iso-
lated Golgi complexes in vitro. Alpha subunits alone were 
unable to stimulate membrane tubules in the absence of BBC 
(Fig. 1 G). However, when 1 or 2 was mixed with sub-
threshold amounts of BBC, catalytically active 1 and 2 
but not inactive enzymes with single amino acid changes 
in active site serines (1 S47A; 2 S48A; Hattori et al., 
1994b) significantly induced Golgi membrane tubule forma-
tion (Fig. 1, C–E). This cytosol requirement was not due 
to LIS1, because 1 or 2 mutants that do not bind to LIS1 
(1 E38D and 2 E39D; Yamaguchi et al., 2007) stimulated 
membrane tubules (Fig. 1 G). Consistent with these results, 
antibodies against 1 and 2 (but not preimmune antisera) 
inhibited BBC-dependent in vitro Golgi membrane tubulation 
(Fig. 1 F), whereas the addition of LIS1 antibodies had no ef-
fect (unpublished data). These results show that PAFAH Ib 
catalytic activity is required for stimulating membrane tu-
bules from isolated Golgi complexes.
in spermatogenesis, are otherwise normal (Koizumi et al., 2003; 
Yan et al., 2003).
Using multiple in vitro and in vivo approaches, we find 
that all three subunits of PAFAH Ib contribute to the structure of 
the mammalian Golgi complex, and the catalytic subunits inde-
pendently contribute to secretion. Our results suggest a model 
whereby the PLA2 activity of 1 and 2 remodel membrane 
phospholipids to form Golgi tubules, which are linked via LIS1 
to dynein-mediated, microtubule transport.
Results and discussion
PAFAH Ib 1 and 2 are cytoplasmic 
membrane tubulation factors
Previous studies showed that a preparation of bovine brain 
cytosol (BBC) contains PLA2 activity that stimulates Golgi 
membrane tubule formation in a cell-free system (de Figueiredo 
et al., 1999). Biochemical fractionation of BBC yielded a final 
gel filtration (GF) fraction highly enriched (5,400 fold) in tu-
bulation activity, with native molecular weight of 150–170 kD 
(Banta et al., 1995), and containing cofractionating proteins of 
80, 66, 45, 40, 30, and 18 kD (Fig. 1, A and B). MALDI TOF-TOF 
and Western blotting identified the 45-kD band as LIS1 and the 
29–30-kD bands as 1 and 2 catalytic subunits of PAFAH Ib 
Figure 1. PAFAH Ib catalytic subunits are 
cytosolic Golgi tubulation factors. (A) Peak 
Golgi tubule–stimulating activity (determined 
by an in vitro reconstitution assay) cofractionates 
with PAFAH activity and PAFAH Ib subunits 
(Western blot) in final bovine brain cytosol 
(BBC) fractionation steps. (B) Silver stain of 
final fractions with the minimal components 
that stimulate Golgi tubules in vitro. The com-
ponents identified by MALDI TOF-TOF and/or 
Western blot are labeled (NS = non specific). 
(C) Coomassie-stained gel and PAFAH activity 
of purified subunits. (D) EM of negative stain 
Golgi from in vitro tubulation reconstitution as-
says incubated with BBC and purified subunits 
as indicated. Bars, 500 nm. (E) Quantitation of 
tubulation assay using purified 1 and 2 sub-
units (7.5 µg/ml), with subthreshold BBC (low 
BBC, 0.25 mg/ml) compared with saturating 
BBC (1.5 mg/ml). svPLA2 = snake venom PLA2. 
Results are the percentage of control (BBC), 
n = 4; error bars = SD. (F) Anti-1 and/or anti-2 
antibodies, but not preimmune IgG (PI-1, PI-2), 
inhibit cytosol-stimulated Golgi membrane 
tubules in vitro. BSA = bovine serum albumin. 
Results are percentage of control (BBC), n = 4; 
error bars = SD. (G) Quantitation of tubulation 
with purified wild-type or LIS1-binding defec-
tive 1 E38D and 2 E39D (7.5 µg/ml), in 
the presence or absence of low BBC. Results 
are percentage of control (BBC), n = 3; error 
bars = SEM.
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2 S48A/E39D). These constructs also disrupted the Golgi and 
TGN (Fig. 2, H and I; Fig. S2, A–H).
The LIS1-binding mutant results suggest that catalytic activ-
ity is important, and that  subunits also compete for binding to 
LIS1 to regulate dynein-dependent Golgi structure, in agreement 
with previous reports (Ding et al., 2009). In addition, our results 
agree with Ding et al. (2009), who found that overexpression of 2 
had a more dramatic effect on Golgi positioning. A role for LIS1 
in Golgi structure has been suggested; LIS1+/ mouse embryonic 
fibroblasts had mild Golgi dispersal, and Cos-7 cells overexpress-
ing LIS1 had more compact Golgi complexes (Smith et al., 2000).
Our results suggest a model whereby PAFAH Ib provides a 
link between the initiation of membrane tubule formation and the 
subsequent movement of these tubules along microtubules. 
PAFAH Ib 1 and 2, bound to LIS1, may initiate membrane 
curvature by intrinsic PLA2 activity, thus forming membrane tu-
bules. Subsequently, LIS1 may switch to a LIS1–Ndel1–dynein 
complex, facilitating the minus-end movement of membrane 
tubules along microtubules to the centrosome (Vallee and Tsai, 
2006). This provides a mechanism to couple the formation of 
Golgi membrane tubules to dynein motors for the formation and 
maintenance of a centrally located, intact Golgi ribbon.
Loss of PAFAH Ib fragments the  
Golgi complex, inhibits tubule-mediated 
Golgi assembly, and reduces  
anterograde trafficking
To determine if PAFAH Ib 1 and 2 are required for Golgi struc-
ture and function, siRNA-mediated knockdown experiments were 
conducted. PAFAH Ib 1 and 2 can form catalytically active 
homo- and heterodimers (Manya et al., 1999). Therefore we used 
mixed siRNAs targeting both 1 and 2, reducing expression by 
85.7 ± 3.3% and 81.8 ± 3.8% (n = 7 and 6; ± SEM), respectively, 
which did not affect levels of LIS1 (Fig. 3 A). As a consequence of 
1 and 2 loss, the Golgi complex, ER-Golgi intermediate com-
partment (ERGIC), and the TGN became fragmented (Fig. 3, B–D; 
Fig. S3, A and B). Confocal microscopy revealed that fragmented 
Golgi puncta contained multiple cisternal markers, indicating that 
loss of 1 and 2 resulted in the formation of mini-stacks (Fig. 3 D; 
Fig. S3 C), which was confirmed by transmission EM (Fig. 3 E). 
Similar fragmentation was seen with knockdown of LIS1, which 
could be rescued by expressing RNAi-resistant HA-LIS1 (Fig. 3, 
F–H), similar to other recent studies (Lam et al., 2010).
Membrane tubule–mediated assembly and maintenance 
of an intact Golgi ribbon is inhibited by PLA2 antagonists 
(de Figueiredo et al., 1999). To determine if knockdown of PAFAH 
Ib subunits similarly inhibits these tubules, we examined the re-
assembly of the Golgi during recovery from brefeldin A (BFA). 
After washout of BFA, the Golgi reassembles into separate 
mini-stacks that subsequently coalesce via membrane tubules 
into an intact ribbon (de Figueiredo et al., 1999). Knockdown of 
1 and 2 or LIS1 had no apparent effect on BFA-stimulated 
retrograde movement of Golgi enzymes to the ER (unpublished 
data). Upon washout, the emergence of separate Golgi mini-
stacks was unaffected by knockdown of PAFAH Ib subunits. 
In contrast, knockdown of 1 and 2 or LIS1 significantly 
inhibited subsequent coalescence into intact ribbons (Fig. 4, A–D), 
PAFAH Ib 1 and 2 partially localize to 
Golgi membranes and tubules
In mildly expressing cells, catalytically active HA-tagged 1 or 
2 (Fig. 1 C) was found diffuse throughout the cytoplasm, in 
the nucleus, on punctate structures, and clearly on intracellular 
structures in the juxtanuclear region that colocalized with Golgi 
markers including Rab6-GFP (cis), GPP130 (cis), mannosidase II 
(ManII, medial), and mannose 6-phosphate receptors (M6PR, 
TGN; Fig. 2, A and B; Fig. S1 A; unpublished data). A similar 
distribution was seen by Caspi et al. (2003) in cells expressing 
GFP-1. Catalytically inactive 1 S47A and 2 S48A, as well 
as 1 E38D and 2 E39D, were similarly localized (Fig. S1 A; 
unpublished data), indicating that catalytic activity and LIS1 
binding are not required for 1 or 2 association with Golgi 
membranes. In addition to centrosomal and cytoplasmic local-
ization, HA-tagged LIS1 was observed to surround the Golgi 
complex (Fig. 2, D and F), consistent with reports that a small 
fraction of LIS1 is membrane associated (Lam et al., 2010). 
PAFAH Ib 1 could also be found localized to membrane tu-
bules (Fig. 2, E and G; Fig. S1 B). Consistent with the imaging 
results, we found that a fraction of both 1 and LIS1 cofraction-
ated with Golgi membranes in sucrose gradients (Fig. 2 C).
PAFAH Ib 1 and 2 overexpression 
reveals a connection between PLA2  
activity and LIS1-mediated regulation  
of Golgi structure
Overexpression of 1 or 2 resulted in a fragmented or com-
pletely dispersed Golgi and TGN (Fig. 2, H and I; Fig. S2), which 
was more severe in 2-overexpressing cells (Fig. S2, A, C, and D). 
Changes in Golgi structure were not observed when cells overex-
pressed an unrelated cytoplasmic PLA2, iPLA2 (unpublished 
data). Overexpression of catalytically inactive 1 S47A or 2 
S48A also caused the Golgi and TGN to become fragmented or 
diffuse (Fig. 2, H and I; Fig. S2). Overexpression of catalytically 
inactive 1 or 2 may produce a dominant-negative effect by 
forming poisonous dimers, competing with endogenous 1 and 
2 for binding to membranes, and/or by titrating LIS1, thus in-
hibiting the ability of LIS1 to regulate dynein (Vallee and Tsai, 
2006; Kerjan and Gleeson, 2007; Ding et al., 2009).
Microtubules and dynein-mediated centripetal positioning 
are required for the maintenance of an intact mammalian Golgi 
near the centrosome (Corthésy-Theulaz et al., 1992). To deter-
mine if overexpression of 1 and 2 affected Golgi structure by 
binding to and influencing LIS1 function, cells were transfected 
with the LIS1-binding mutants 1 E38D or 2 E39D. 2 E39D 
did disrupt the Golgi and TGN, albeit less severely than 2 wild-
type or 2 S48A (Fig. 2 I; Fig. S2, D and E). In contrast to wild-
type and catalytically inactive 1, overexpression of equivalent 
levels of 1 E38D did not significantly disrupt the Golgi or TGN 
(Fig. 2, H and I; Fig. S2, A–J), indicating that the Golgi disruption 
produced by 1 and 1 S47A are partially due to interactions 
with LIS1.
To determine if catalytic activity of 1 and 2 is also im-
portant for maintaining Golgi structure in vivo, independent of 
LIS1, cells were transfected with a double mutant that is both cat-
alytically inactive and unable to bind LIS1 (1 S47A/E38D; 
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Figure 2. PAFAH Ib partially localizes to Golgi membranes and overexpression of catalytic subunits perturbs Golgi and TGN structure. (A) Confocal micros-
copy of cells mildly overexpressing 1 (HA tagged) and Rab6-GFP. Box indicates region in bottom panels. (B) Fluorescence intensity line plot of 1 and Rab6-
GFP from bottom panel of A. (C) Western blot showing 1 and LIS1 cofractionate with Golgi (ManII) by sucrose-density cell fractionation. Bracket indicates 
nonspecific bands. (D) Confocal slice shows HA-LIS1 localizes around the Golgi (ManII). (E) 1 localizes to Golgi tubules. Arrowheads indicate colocaliza-
tion with Rab6-GFP membrane tubules. (F) Line fluorescence intensity plot of LIS1 concentrated around Golgi complexes (from line in D). (G) Line fluorescence 
intensity of 1 on membrane tubules (from line in E). (H) HeLa cells transfected with the indicated 1 (HA tagged) and double labeled for HA and either a 
Golgi (GPP130) or TGN marker (M6PR). Overexpression of 1 wild type, 1 S47A (catalytic mutant), or 1 S47A/E38D (catalytic and LIS1-binding mutant) 
disrupted the structure of the Golgi and the TGN. Asterisks and arrowheads indicate transfected and untransfected cells, respectively. (I) Quantitation of HeLa 
and BTRD cells with disrupted Golgi structure in cells transfected as indicated. Weighted means shown, n = 3; error bars = SEM; *, P < 0.05 compared with 
untransfected cells; **, P < 0.001 compared with 1 E38D (Behrens-Welch test). Bars: (A, bottom, and E) 5 µm; (A, top, D, and H) 10 µm.
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roles in TGN-to-plasma membrane trafficking. The reduced trans-
port of VSV-G with 1 and 2 knockdown could be partially res-
cued by the reintroduction of equivalent levels of RNAi-resistant 
1, but not RNAi-resistant 1 S47A, indicating that PLA2 activity 
is important for regulating the transport of Golgi to plasma mem-
brane cargo (Fig. 5 A, D; Fig. S2, I and J). Likewise, secretion of 
soluble cargo, ssHRP, was significantly inhibited in 1 and 2 
knockdown cells (Fig. 5 E). Thus, loss of 1 and 2 may directly 
decrease TGN-to-plasma membrane tubulo-vesicular carriers 
(Bard and Malhotra, 2006; De Matteis and Luini, 2008).
Loss of 1 and 2 could also influence Golgi trafficking by 
affecting any number of components that require specific lipids 
for binding. Export from the TGN requires protein kinase D 
(PKD), which binds to membranes via diacylglycerol (Baron and 
Malhotra, 2002). A kinase-dead (KD) version of PKD, which in-
hibits TGN tubule fission (Bard and Malhotra, 2006), is a conve-
nient marker for PKD association with the TGN. In 1 and 2 
knockdown cells, PKD-KD-GFP underwent redistribution from 
the TGN to the cytoplasm and plasma membrane (Fig. S3 D). The 
structure and function of the Golgi and TGN is also dependent on 
COPI vesicles, AP-1 clathrin-coated vesicles, and microtubules; 
which could be rescued by expressing RNAi-resistant LIS1 
(Fig. 4, C and D).Importantly, unlike 1 and 2 knockdown, 
LIS1 knockdown Golgi mini-stacks displayed numerous mem-
brane tubules, which were no longer seen when all three subunits 
were knocked down (Fig. 4, E and F). These results are consistent 
with our in vitro and overexpression studies and further support 
the conclusion that the catalytic 1 and 2 subunits of PAFAH Ib 
are capable of inducing membrane tubules in vivo. The mem-
brane tubules that form in LIS1 knockdown cells are dependent 
on 1 and 2, but directed movement for mini-stack coalescence 
is inhibited in the absence of LIS1-mediated dynein interactions.
In addition to reassembly of the Golgi complex, mem-
brane tubules are implicated in export from the TGN and secre-
tion (Bard and Malhotra, 2006; De Matteis and Luini, 2008). 
Using ts045VSV-G as a transmembrane cargo, we found that 
transport from the ER to the Golgi complex was unaffected in 
1 and 2 knockdown cells (Fig. 5, A and B). In contrast, 
export of ts045VSV-G from the TGN to the cell surface was 
significantly slowed in 1 and 2 knockdown cells (Fig. 5, 
A, C, and D). VSV-G transport was unchanged with LIS1 knock-
down (Fig. 5 F), suggesting 1 and 2 have LIS1-independent 
Figure 3. PAFAH Ib subunits are important for maintaining an intact Golgi ribbon. (A) Western blot of PAFAH Ib subunits in control and 1/2 siRNA-
treated (72 h) BTRD cells. (B) Confocal stack of the Golgi (ManII) in control and 1/2 siRNA-transfected cells. (C) The fraction of cells with fragmented 
Golgi. n = 7; error bars = SEM; P < 0.001 by t test. (D) 3D reconstructions of Golgi from confocal z-series of control and 1/2 siRNA-treated cells visual-
ized with anti-ManII (medial marker, red) and GalT-GFP (trans marker, green). (E) Electron micrographs from control and 1/2 siRNA knockdown cells. 
(F) Western blot 48 h after transfection of control BTRD cells, LIS1 siRNA-transfected cells, and LIS1 knockdown cells overexpressing RNAi-resistant HA-LIS1. 
(G) Wide-field fluorescence image of the Golgi (ManII) in control and LIS1 siRNA-transfected BTRD cells. (H) Fraction of cells with fragmented Golgi. n = 3; 
error bars = SEM. Bars: (B) 2 µm; (D and E) 500 nm; (G) 10 µm.
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cis-to-trans, inter-cisternal trafficking. Interestingly, loss of 
cPLA2 can be compensated by PAFAH Ib 1 (San Pietro 
et al., 2009). cPLA2 was also shown to regulate export from 
the TGN (Regan-Klapisz et al., 2009). Other recent studies 
found that another phospholipase, iPLA1, contributes to 
tubule-mediated retrograde trafficking from the Golgi (Morikawa 
et al., 2009). Although the molecular mechanisms are unclear, 
continual phospholipid remodeling by PLA1, PLA2, and lyso-
phosphatidyl acyltransferase enzymes, such as LPAAT3/AGPAT3 
however, we found that knockdown had no discernable effect 
on -COP, AP-1, or tubulin (Fig. S3, E and F). Similarly, the 
COPII vesicle component Sec31 was unaffected (Fig. S3 E). 
These results suggest that 1 and 2 contribute to phospholipid 
remodeling that is important for PKD association with the TGN.
It is becoming clear that Golgi structure and membrane 
trafficking require constant and complex phospholipid remod-
eling. In addition to PAFAH Ib, cPLA2 has recently been 
shown to influence the Golgi by regulating tubule-mediated, 
Figure 4. Golgi ribbon reassembly is impaired in PAFAH Ib knockdown cells. (A) Confocal images of the Golgi (anti-ManII) before BFA, after 20 min in BFA 
(0 min), and 20, 45, or 90 min after BFA washout in control or 1 and 2 siRNA-transfected cells. (B) Percentage of cells with reassembled Golgi ribbons 
after BFA washout. n = 4; error bars = SEM; at 90 min P < 0.01 by t test. (C) Wide-field fluorescence images of the Golgi (anti-ManII) before BFA treatment, 
and after 0, 20, 45, or 60 min of BFA washout. RNAi-resistant HA-LIS1 expression is shown in insets (anti-HA). (D) Percentage of cells with reassembled 
Golgi ribbons; n = 3; error bars = SEM. (E) Golgi mini-stacks (anti-ManII) after 30 min of BFA recovery for 1 and 2 siRNA or LIS1 siRNA, or 1/2/LIS1 
siRNA (triple)-treated BTRD cells. LIS1 knockdown cells show extensive membrane tubules, which are not seen in 1 and 2 or triple knockdown cells. 
(F) Percentage of cells with Golgi tubules after 30 min of BFA washout. Bars: (A and C) 10 µm; (E) 5 µm.
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anti-1 and -2 in initial studies (K. Inoue, University of Tokyo, Tokyo, 
Japan); guinea pig and rabbit anti-1 and -2 antibodies (character-
ized here); rabbit anti-bovine CI-M6PR (by us [Brown and Farquhar, 
1987]); rabbit anti-dynamin (MC63; M. McNiven, Mayo Clinic, Roch-
ester, MN); rabbit anti–human GPP130 (A. Linstedt, Carnegie Mellon 
University, Pittsburgh, PA); rabbit anti-ManII (K. Moremen, University of 
Georgia, Athens, GA); chicken anti-2 (Abcam); mouse anti-LIS1 
(Sigma-Aldrich); mouse anti-HA (Sigma-Aldrich and Covance); mouse 
anti–-COP (BioMakor), mouse anti–-tubulin (Sigma-Aldrich), rabbit 
anti–-adaptin (Santa Cruz Biotechnology, Inc.), rabbit anti-Sec31A 
(W. Balch, Scripps Research Institute, La Jolla, CA); fluorescent second-
ary antibodies (Jackson ImmunoResearch Laboratories, Inc. and Invitro-
gen); HRP-conjugated goat anti–chicken (Aves Laboratories), anti–guinea 
pig (Pocono Rabbit Farm and Laboratory), anti–rabbit (GE Healthcare), 
and anti-mouse (Invitrogen).
Preparation of plasmids
Bovine PAFAH Ib 1 and 2, pUC-PL-cI-1, and pUC-PL-cI-2 (Hattori 
et al., 1995) were gifts from Dr. Inoue. These were templates for 1-S47A 
and 2-S48A, which were made by PCR and ligation into pGEX6P1 
(GE Healthcare) BamHI sites.
Tagging 1 and 2 on the N and C termini was problematic because 
such proteins were inactive. Although our polyclonal antibodies were useful 
for Western blots, we were unsuccessful in localizing endogenous 1 and 
2 with many different polyclonal antibodies (made in rabbit, guinea pig, 
(Schmidt and Brown, 2009), may be critical for regulating 
the availability of curvature-altering lipids such as lysophos-
pholipids, phosphatidic acid, diacylglycerol, and/or for the 
recruitment of other membrane-trafficking proteins, such as 
PKD (Bankaitis, 2009).
Our results demonstrate a novel role for PAFAH Ib PLA2 
 subunits, which appear to be multi-functional, regulating 
PAF signaling, LIS1 function in dynein-mediated processes, 
and, as shown here, the formation of membrane tubules and 
the function of the Golgi complex. Our studies reveal a novel 
relationship of PAFAH Ib PLA2 activity with dynein-dependent 
processes that are coupled by LIS1 to regulate Golgi structure. 
Additionally, our results show that 1 and 2 have a LIS1-
 independent role in export from the TGN.
Materials and methods
Materials
Sprague-Dawley male rats were from Charles River; BFA and cyclohexi-
mide from Enzo Life Sciences, Inc. Antibodies were as follows: rabbit 
Figure 5. PAFAH Ib 1 and 2 are important for the transport of both transmembrane and soluble cargo. (A) Confocal stacks of ts045VSV-G-YFP after release 
from a 20°C TGN block in control, 1 and 2 siRNA-transfected, and either 1 and 2 siRNA + RNAi-resistant 1 or catalytic mutant 1 S47A-transfected BTRD 
cells. Insets show anti-HA, indicating 1 or 1 S47A-transfected cells. (B) Anterograde transport of ts045VSV-G from the ER to the Golgi. VSV-G-YFP fluorescence 
in the Golgi after release from a 40°C block to 20°C. Lines correspond to first order kinetic equations: control k = 0.10 ± 0.02 and siRNA k = 0.07 ± 0.02, ± 
SEM. Difference in kinetic constants was not statistically significant; P < 0.25 (t test). (C) Fluorescence intensity of post-TGN VSV-G-YFP fluorescence after release 
from 20°C. Lines correspond to first order kinetic equations, control k = 0.027 ± 0.005 and siRNA k = 0.013 ± 0.003, ± SEM; P < 0.05 (t test). (D) Fluorescence 
intensity of post-TGN VSV-G-YFP fluorescence after release from 20°C for control, 1 and 2 siRNA, and siRNA cells transfected with RNAi-resistant 1 or 1 
S47A (catalytic mutant). (B–D) n = 3–4; error bars = SEM. (E) Secretion of ssHRP-Flag in control and 1 and 2 siRNA treated BTRD cells. Media HRP activity was 
measured and normalized to total HRP expression, expressed as a fraction of secreted HRP at 8 h in control cells. The rates of secretion were: control = 0.121 ± 
0.003, 1 and 2 siRNA = 0.068 ± 0.008, ± SEM; n = 8; error bars = SEM. (F) VSV-G-YFP is transported from the Golgi to the plasma membrane in LIS1 siRNA-
treated BTRD cells with rates similar to control cells, as seen by wide-field fluorescence. Bars, 10 µm.
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Fluorescence and electron microscopy
Cells were prepared as described previously (de Figueiredo et al., 1999, 
2001). Either GFP- or YFP-tagged proteins or secondary antibodies conju-
gated to Alexa 488, DyLight 488, fluorescein isothiocyanate, tetramethylrho-
damine isothiocyanate, or Cy5 were used. Coverslips were mounted with 
Vectashield (Vector Laboratories) mounting media and imaged at room tem-
perature. Wide-field epifluorescence was with a microscope (Axioscope II; 
Carl Zeiss, Inc.) with 40x or 100x Plan-Apochromat NA1.4 oil objective 
lenses, a digital camera (Orca II; Hamamatsu Photonics), and Openlab soft-
ware (PerkinElmer). Spinning disk confocal images were from a microscope 
(Eclipse TE2000-U; Nikon) with Plan-Apo 60x/NA1.4 or Plan-Apo100x/
NA1.4 oil objectives, with an Ultraview LCI (PerkinElmer), a camera (1394 
ORCA-ER; Hamamatsu Photonics), and Ultraview software (PerkinElmer). 
A microscope (DMI6000B; Leica) equipped with an oil 63x/NA1.4 objec-
tive, 3i Marianas spinning disk system, Photometrics HQII CCD camera, and 
3i Slidebook 5.0 software was also used (Intelligent Imaging Innovations). 
For electron microscopy, FEI Morgagni 268 transmission EM was used.
VSV-G-YFP and ssHRP-Flag
ts045VSV-G-YFP pixel intensities of the juxtanuclear Golgi region and total 
cell were measured from confocal images using ImageJ (National Institutes 
of Health, Bethesda, MD), with appropriate background fluorescence sub-
traction (per area). Kinetic equations for ts045VSVG-YFP transport were fit 
by least squares nonlinear regression using Origin 3.5 software, based on 
first order kinetic equations (Hirschberg et al., 1998). For ssHRP-Flag mea-
surements, media and lysate HRP activity was quantified by absorbance, 
using 3, 3, 5, 5-tetramethylbenzidine reagent (Sigma-Aldrich), and nor-
malized to total HRP expression.
Image analysis and statistics
The Golgi disruption indices were by categorizing Golgi as diffuse, frag-
mented, or intact. For most experiments, ≥ 300 cells were counted for each 
condition, and each was repeated independently at least three times. The 
statistical significance between control and knockdown cells was with a 
two-tailed, unequal variance t test. The significance of overexpression pheno-
types was by Behrens-Welch testing. Images and z-projections were cropped, 
brightness adjusted, or contrast adjusted using ImageJ, Photoshop CS3, or 
using 3i Slidebook 5.0 software. 3D reconstruction was done using Volocity 
software (PerkinElmer). Line intensity plots were done using 3i Slidebook 
5.0 software (Intelligent Imaging Innovations).
Online supplemental material
Fig. S1 shows the localization of 1, 2, 2 S48A, or 1 S47A/E38D 
to multiple Golgi cisternae and TGN membrane tubules. Fig. S2 shows 
Golgi and TGN structure is disrupted upon overexpression of 1, 2, and 
various mutant 1 and 2 versions in HeLa and BTRD cell lines. Fig. S3 
shows fragmentation of the ERGIC and TGN, and that the TGN is associ-
ated with Golgi mini-stacks with loss of 1 and 2 in siRNA knockdown 
experiments. Fig. S3 shows vesicle markers and microtubules are un-
affected, whereas PKD-KD-GFP localization is changed upon 1 and 2 
knockdown. Online supplemental material is available at http://www.jcb 
.org/cgi/content/full/jcb.200908105/DC1.
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